Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Nicotinamide breaks effector CD8 T cell responses by targeting mTOR signaling

Published:2022-03 Issue:3 Volume:25 Page:103932
ISSN:2589-0042
Container-title:iScience
language:en
Short-container-title:iScience

Author:

Agliano Federica^ORCID,Karginov Timofey A.^ORCID,Ménoret Antoine,Provatas Anthony^ORCID,Vella Anthony T.

Publisher

Elsevier BV

Subject

Multidisciplinary

Reference68 articles.

1. mTOR regulates memory CD8 T-cell differentiation;Araki;Nature,2009

2. Nicotinamide treatment ameliorates the course of experimental colitis mediated by enhanced neutrophil-specific antibacterial clearance;Bettenworth;Mol. Nutr. Food Res.,2014

3. Inhibition of silencing and accelerated aging by nicotinamide, a putative negative regulator of yeast sir2 and human SIRT1;Bitterman;J. Biol. Chem.,2002

4. Potential roles of gut microbiome and metabolites in modulating ALS in mice;Blacher;Nature,2019

5. Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition;Bogan;Annu. Rev. Nutr.,2008

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. S-nitrosoglutathione (GSNO) induces necroptotic cell death in K562 cells: Involvement of p73, TSC2 and SIRT1;Cellular Signalling;2024-12

2. The ecto-enzyme CD38 modulates CD4T cell immunometabolic responses and participates in HIV pathogenesis;Journal of Leukocyte Biology;2024-03-11

3. Obesity, bone marrow adiposity, and leukemia: Time to act;Obesity Reviews;2023-12-13

4. NAD+: An old but promising therapeutic agent for skeletal muscle ageing;Ageing Research Reviews;2023-12

5. Evaluating the glycolytic potential of mouse costimulated effector CD8+ T cells ex vivo;STAR Protocols;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3